Assignee
BIRDIE BIOPHARMACEUTICALS INC
KY·20 granted patents·17 pending applications·180 citations·filing 2015–2025
Top patents by PatentIndex Score
37 records- 0197US10744206B2Compounds and compositions for immunotherapyBIRDIE BIOPHARMACEUTICALS INC·Filed 2019·Granted Aug 18, 2020·14 cites·41 claims
- 0297US9827329B2Compounds and compositions for immunotherapyBIRDIE BIOPHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·28 cites·24 claims
- 0396US11053240B22-amino-quinoline derivativesBIRDIE BIOPHARMACEUTICALS INC·Filed 2018·Granted Jul 6, 2021·23 cites·34 claims
- 0496US10780180B2Compounds and compositions for immunotherapyBIRDIE BIOPHARMACEUTICALS INC·Filed 2019·Granted Sep 22, 2020·11 cites·27 claims
- 0596US10660971B2Compounds for targeted immunotherapyBIRDIE BIOPHARMACEUTICALS INC·Filed 2017·Granted May 26, 2020·14 cites·17 claims
- 0695US11279761B2Anti-PD-L1 combinations for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2018·Granted Mar 22, 2022·7 cites·12 claims
- 0795US10548988B2Compounds for targeted immunotherapyBIRDIE BIOPHARMACEUTICALS INC·Filed 2017·Granted Feb 4, 2020·14 cites·22 claims
- 0895US10328158B2Compounds and compositions for immunotherapyBIRDIE BIOPHARMACEUTICALS INC·Filed 2017·Granted Jun 25, 2019·15 cites·38 claims
- 0993US10548985B2Compounds and compositions for treating EGFR expressing tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2015·Granted Feb 4, 2020·11 cites·16 claims
- 1092US11220552B2Anti-CD20 combinations for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2017·Granted Jan 11, 2022·7 cites·11 claims
- 1192US11046781B2Anti-HER2 combinations for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2017·Granted Jun 29, 2021·11 cites·13 claims
- 1290US11136397B2Anti-EGFR combinations for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2017·Granted Oct 5, 2021·9 cites·15 claims
- 1390US11130812B2Anti PD-L1 conjugates for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2015·Granted Sep 28, 2021·10 cites·17 claims
- 1487US11633495B2Compounds and compositions for immunotherapyBIRDIE BIOPHARMACEUTICALS INC·Filed 2020·Granted Apr 25, 2023·1 cites·44 claims
- 1587US11633494B2Compounds and compositions for immunotherapyBIRDIE BIOPHARMACEUTICALS INC·Filed 2020·Granted Apr 25, 2023·1 cites·29 claims
- 1687US2026049145A1Anti-pd-l1 combinations for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1786US2023390410A1Compounds and compositions for immunotherapyBIRDIE BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1885US11517567B2Pharmaceutical compositionsBIRDIE BIOPHARMACEUTICALS INC·Filed 2017·Granted Dec 6, 2022·4 cites·21 claims
- 1977US12295950B2Pharmaceutical compositionsBIRDIE BIOPHARMACEUTICALS INC·Filed 2022·Granted May 13, 2025·0 cites·22 claims
- 2077US2022251212A1Anti-pd-l1 combinations for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2174US11786604B2Compounds and compositions for treating HER2 positive tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2020·Granted Oct 17, 2023·0 cites·21 claims
- 2269US2020179527A1Compounds for targeted immunotherapyBIRDIE BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2369US2020246478A1Compounds for targeted immunotherapyBIRDIE BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2468US2021363271A1Anti-her2 combinations for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2568US2021347911A1Anti-her2 combinations for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2667US2022204641A1Anti-cd20 combinations for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2767US2019048084A1Anti-pd-l1 combinations for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2866US11702476B2Anti-EGFR combinations for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2021·Granted Jul 18, 2023·0 cites·12 claims
- 2966US2017114137A1Anti-pd-l1 combinations for treating tumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3064US11834448B22-amino-quinoline derivativesBIRDIE BIOPHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·0 cites·44 claims
- 3160US2022033503A1Anti PD-L1 Conjugates for Treating TumorsBIRDIE BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3256US2019099415A1Combination therapy compositions and methods for treating cancersBIRDIE BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3355US2017056391A1Combination therapy compositions and methods for treating cancersBIRDIE BIOPHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3450US2022016152A1Immune modulatory combinations and methods for treating cancersBIRDIE BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3549US2022175762A1Immune modulatory compositions and methods for treating cancersBIRDIE BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3647US2021214354A1Imidazoquinoline compounds and uses thereofBIRDIE BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3747US2024382469A1Combination therapy with deuterated imidazoquinolinesBIRDIE BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIRDIE BIOPHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →